ArticleEuropean journal of medical research2025
Systemic inflammatory response index: a novel predictor for cardiovascular disease risk in patients with primary biliary cholangitis.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association between systemic inflammation response index and risk of major adverse cardiovascular events in adults with and without metabolic syndrome: a prospective cohort study in Shanghai, Pudong.Frontiers in endocrinology · 2026Article
- Preoperative differentiation of acute appendicitis using NLR, SII, and maximum appendiceal diameter: a retrospective single-center diagnostic study.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCardiovascular disease (CVD) is a significant concern in patients with primary biliary cholangitis (PBC) due to the combined effects of immune dysregulation and chronic inflammation. Traditional biomarkers may have limited predictive value for CVD in this population. This study aims to investigate the relationship between inflammatory biomarkers and CVD in patients with PBC.
methodsPatients with PBC who were treated at Beijing Ditan Hospital between January 2018 and December 2022 were included. Multivariate logistic regression models were performed to investigate the association between systemic inflammatory response index (SIRI), systemic immune inflammatory index (SII), neutrophil-to-lymphocyte ratio (NLR), and monocyte-to-lymphocyte ratio (MLR) and CVD. The predictive value of inflammatory biomarkers for CVD was evaluated using receiver operating characteristic (ROC) curves. In addition, a restricted cubic spline (RCS) fitted with a logistic regression model was used to analyze the relationship between SIRI and CVD.
resultsThe prevalence of CVD in patients with PBC was 16.9% (n = 71). Multivariate logistic regression analysis showed that SIRI was an independent risk factor for CVD prevalence. Each standard deviation increase in SIRI was associated with a 79.2% increased risk of CVD (OR = 1.792, 95%CI = 1.348-2.382, P < 0.001). SIRI demonstrated moderate predictive ability for CVD, with an area under the curve (AUC) of 0.725. However, it was superior to NLR (AUC = 0.626), MLR (AUC = 0.579) and SII (AUC = 0.599). Subgroup analysis showed that the association between SIRI and CVD risk was robust with respect to gender, body mass index, smoking, drinking, hypertension, and diabetes mellitus, except for older age and cirrhosis status. The RCS analysis showed a stable linear relationship between SIRI and CVD, with significantly increased odds of CVD for SIRI values > 0.65.
conclusionSIRI is a promising inflammatory biomarker and is independently associated with CVD prevalence in patients with PBC. Clinicians may consider incorporating SIRI into clinical practice to better stratify CVD risk and guide preventive strategies in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.